These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
619 related articles for article (PubMed ID: 7910522)
1. Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Schinkel AH; Smit JJ; van Tellingen O; Beijnen JH; Wagenaar E; van Deemter L; Mol CA; van der Valk MA; Robanus-Maandag EC; te Riele HP Cell; 1994 May; 77(4):491-502. PubMed ID: 7910522 [TBL] [Abstract][Full Text] [Related]
2. Homozygous disruption of the mdrla P-glycoprotein gene affects blood-nerve barrier function in mice administered with neurotoxic drugs. Saito T; Zhang ZJ; Ohtsubo T; Noda I; Shibamori Y; Yamamoto T; Saito H Acta Otolaryngol; 2001 Sep; 121(6):735-42. PubMed ID: 11678173 [TBL] [Abstract][Full Text] [Related]
3. Brain penetration of ivermectin and selamectin in mdr1a,b P-glycoprotein- and bcrp- deficient knockout mice. Geyer J; Gavrilova O; Petzinger E J Vet Pharmacol Ther; 2009 Feb; 32(1):87-96. PubMed ID: 19161460 [TBL] [Abstract][Full Text] [Related]
4. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice. van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431 [TBL] [Abstract][Full Text] [Related]
5. Disruption of mdr1a p-glycoprotein gene results in dysfunction of blood-inner ear barrier in mice. Zhang ZJ; Saito T; Kimura Y; Sugimoto C; Ohtsubo T; Saito H Brain Res; 2000 Jan; 852(1):116-26. PubMed ID: 10661503 [TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A and trifluoperazine, two resistance-modulating agents, increase ivermectin neurotoxicity in mice. Marques-Santos LF; Bernardo RR; de Paula EF; Rumjanek VM Pharmacol Toxicol; 1999 Mar; 84(3):125-9. PubMed ID: 10193673 [TBL] [Abstract][Full Text] [Related]
7. Inhibitory effect of cyclosporin A on p-glycoprotein function in peripheral nerves of mice treated with doxorubicin and vinblastine. Saito T; Zhang ZJ; Ohtsubo T; Noda I; Tokuriki M; Shibamori Y; Yamamoto T; Saito H Acta Otolaryngol; 2004 Apr; 124(3):313-7. PubMed ID: 15141761 [TBL] [Abstract][Full Text] [Related]
8. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease. Smit JJ; Schinkel AH; Oude Elferink RP; Groen AK; Wagenaar E; van Deemter L; Mol CA; Ottenhoff R; van der Lugt NM; van Roon MA Cell; 1993 Nov; 75(3):451-62. PubMed ID: 8106172 [TBL] [Abstract][Full Text] [Related]
9. Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. Schinkel AH; Wagenaar E; van Deemter L; Mol CA; Borst P J Clin Invest; 1995 Oct; 96(4):1698-705. PubMed ID: 7560060 [TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs. Schinkel AH; Wagenaar E; Mol CA; van Deemter L J Clin Invest; 1996 Jun; 97(11):2517-24. PubMed ID: 8647944 [TBL] [Abstract][Full Text] [Related]
12. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug. Jonker JW; Wagenaar E; van Deemter L; Gottschlich R; Bender HM; Dasenbrock J; Schinkel AH Br J Pharmacol; 1999 May; 127(1):43-50. PubMed ID: 10369454 [TBL] [Abstract][Full Text] [Related]
13. Penetration of amitriptyline, but not of fluoxetine, into brain is enhanced in mice with blood-brain barrier deficiency due to mdr1a P-glycoprotein gene disruption. Uhr M; Steckler T; Yassouridis A; Holsboer F Neuropsychopharmacology; 2000 Apr; 22(4):380-7. PubMed ID: 10700657 [TBL] [Abstract][Full Text] [Related]
14. Comparative pharmacokinetics of vinblastine after a 96-hour continuous infusion in wild-type mice and mice lacking mdr1a P-glycoprotein. van Asperen J; van Tellingen O; Schinkel AH; Beijnen JH J Pharmacol Exp Ther; 1999 Apr; 289(1):329-33. PubMed ID: 10087021 [TBL] [Abstract][Full Text] [Related]
15. Influence of breast cancer resistance protein (Abcg2) and p-glycoprotein (Abcb1a) on the transport of imatinib mesylate (Gleevec) across the mouse blood-brain barrier. Bihorel S; Camenisch G; Lemaire M; Scherrmann JM J Neurochem; 2007 Sep; 102(6):1749-1757. PubMed ID: 17696988 [TBL] [Abstract][Full Text] [Related]
16. Alternate overexpression of two P-glycoprotein [corrected] genes is associated with changes in multidrug resistance in a J774.2 cell line. Lothstein L; Hsu SI; Horwitz SB; Greenberger LM J Biol Chem; 1989 Sep; 264(27):16054-8. PubMed ID: 2570778 [TBL] [Abstract][Full Text] [Related]
17. Characterization of phosphine complexes of technetium(III) as transport substrates of the multidrug resistance P-glycoprotein and functional markers of P-glycoprotein at the blood-brain barrier. Luker GD; Rao VV; Crankshaw CL; Dahlheimer J; Piwnica-Worms D Biochemistry; 1997 Nov; 36(46):14218-27. PubMed ID: 9369495 [TBL] [Abstract][Full Text] [Related]
18. Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates. Schrenk D; Gant TW; Preisegger KH; Silverman JA; Marino PA; Thorgeirsson SS Hepatology; 1993 May; 17(5):854-60. PubMed ID: 8098315 [TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance and the role of P-glycoprotein knockout mice. Schinkel AH; Mol CA; Wagenaar E; van Deemter L; Smit JJ; Borst P Eur J Cancer; 1995; 31A(7-8):1295-8. PubMed ID: 7577039 [TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites. Cordon-Cardo C; O'Brien JP; Casals D; Rittman-Grauer L; Biedler JL; Melamed MR; Bertino JR Proc Natl Acad Sci U S A; 1989 Jan; 86(2):695-8. PubMed ID: 2563168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]